Al Zahra Hospital
Al Zahra Hospital is a multi-specialty hospital in Dubai providing comprehensive medical and surgical services across a wide range of clinical disciplines. The hospital is equipped with advanced diagnostic and treatment technologies and focuses on delivering patient-centered care in a modern healthcare environment.
Supported by experienced physicians and multidisciplinary healthcare teams, Al Zahra Hospital emphasizes clinical quality, safety, and evidence-based practice. The hospital delivers services aligned with international healthcare standards and contributes to Dubai’s growing and diverse healthcare system.
Dr. Ahmed Soliman
License: DHA
20 years of experience
Dr. Ahmed Soliman is a Consultant in Anatomic Pathology currently practicing at Al Zahra Pvt. Hospital Dubai. He holds FRCPath qualifications and has extensive experience in surgical pathology, clinical research, and medical education. Dr. Soliman is an active member of the Mohs multidisciplinary team and has served as Clinical Lead in Head and Neck Pathology and Deputy Lead in Gynaecology and Cancers of Unknown Primary.
He is also involved in national External Quality Assurance (EQA) schemes and maintains a strong commitment to continuous professional development. In addition to his clinical work, he tutors and examines medical students at Liverpool Medical School.
Dr. Soliman has supervised biomedical scientists progressing toward advanced practitioner roles. Fluent in both English and Arabic, he combines diagnostic expertise with a strong dedication to teaching and advancing pathology practices to improve patient care.
Dr. Peter Baptista
License: DHA
25 years of experience
Dr. Peter Baptista Jardin is a highly acclaimed Specialist ENT Surgeon and Otolaryngologist based in Dubai, with a special focus on the diagnosis and treatment of sleep apnea. He is internationally recognized for performing Spain’s first robotic transoral surgery in 2011 and for pioneering a series of hypoglossal nerve stimulation procedures for obstructive sleep apnea. He currently practices at Al Zahra Hospital, where he provides advanced care for a wide range of ear, nose, and throat disorders.
Dr. Baptista is known for performing innovative ENT procedures that directly address sleep-related breathing disorders, offering a holistic approach to improving sleep quality. He has published extensively in the field of sleep medicine and serves as a respected instructor for sleep apnea courses in Spain. His expertise has been formally recognized with the title of “Expert in Sleep Medicine” by the European Sleep Research Society.
Dr. Sahrkaw Azat Muhyaldeen
License: DHA
17 years of experience
Dr. Sahrkaw Azat Muhyaldeen is a highly experienced Consultant Cardiologist with over 17 years of consultant‑level practice, specializing in cardiac electrophysiology and device therapy. He obtained his medical degree from Mosul Medical School and completed postgraduate training in the UK, earning a Diploma in Internal Medicine with distinction, followed by Membership and Fellowship of the Royal College of Physicians (UK).
His cardiology training included specialist training at Ninewells Hospital in Dundee and research at Good Hope Hospital in Birmingham, where he focused on cardiac resynchronization therapy and produced multiple international publications and presentations. He went on to complete advanced subspecialty training in electrophysiology and device therapy at Queen Elizabeth Hospital, Birmingham.
Dr. Sahrkaw served for more than 18 years at Manchester Royal Infirmary, where he was appointed Consultant Cardiologist and held the role of Electrophysiology Lead for Manchester Foundation Trust. In 2024, he relocated to the UAE and currently practices at Al Zahra Hospital, bringing expertise in complex arrhythmia management, electrophysiology studies, ablation procedures, and the implantation and follow‑up of pacemakers, ICDs, CRT devices, and conduction system pacing systems.
Dr. Pedro Quaresma
License: DHA
20 years of experience
Dr. Pedro Quaresma is a European Board‑Certified Consultant in Nuclear Medicine with over 19 years of experience in both diagnostic and therapeutic nuclear medicine. He has extensive expertise in conventional nuclear medicine, SPECT‑CT, and PET‑CT across oncological and non‑oncological applications. His primary clinical focus is PET‑CT oncological imaging, particularly using 18F‑FDG, along with advanced imaging in orthopaedics, neurology, and cardiology.
Dr. Quaresma previously served as Head of the Nuclear Medicine Department at the Portuguese Armed Forces Hospital. He has also held academic appointments as an invited lecturer in Cardiology at the Nova School of Science and Technology and in Pathophysiology at Nova Medical School in Lisbon. In addition, he is an active speaker at international nuclear medicine conferences across Europe and Dubai, contributing to education, training, and knowledge exchange within the field.
Dr. Mayada Elnegouly
License: DHA
18 years of experience
Dr. Mayada Elnegouly is a German board-certified Consultant Gastroenterologist and Hepatologist with over 18 years of combined clinical and academic experience. She is an Assistant Professor of Gastroenterology and Hepatology and has trained and practiced at leading tertiary university hospitals in Egypt and Germany, including Cairo University Hospitals and Klinikum rechts der Isar at the Technical University of Munich. She currently practices within large, well-established hospital systems in the United Arab Emirates, delivering patient-centered, evidence-based, and multidisciplinary care. Dr. Elnegouly has extensive expertise in diagnostic and advanced therapeutic endoscopy, including EMR, FTRD, EUS with FNA/FNB, bariatric endoscopy, and the management of gastrointestinal bleeding. Her subspecialty interests include GERD, gastrointestinal motility and functional disorders, inflammatory bowel disease with biologic therapies, and pancreaticobiliary diseases. She also has broad hepatology expertise, including fatty and autoimmune liver diseases, liver transplantation care, and gastrointestinal oncology within multidisciplinary cancer teams.
Dr. Ali Chamseddine
License: DHA
15 years of experience
Dr. Ali Chamseddine is a French Board–Certified Consultant Medical Oncologist and Clinical Hematologist with over 15 years of experience in comprehensive cancer care and international training in France and the United States. He holds a PhD in Public Health and Molecular Oncology from the University of Paris-Saclay (summa cum laude) and has made significant contributions to clinical research, including novel methodologies in advanced gastric cancer and over 45 peer-reviewed publications, including in The New England Journal of Medicine. He trained at leading institutions such as Gustave Roussy Cancer Center and MD Anderson Cancer Center, and has held senior consultant and leadership roles in major oncology centers across France and the UAE. In Dubai, he was the founding Head of Oncology at Dr. Sulaiman Al Habib Hospital and currently practices at Al Zahra Hospital Dubai, delivering state-of-the-art, multidisciplinary cancer care. Dr. Chamseddine specializes in precision oncology, treating a broad spectrum of solid tumors and hematologic malignancies, with particular expertise in gastrointestinal, breast, lung, genitourinary, gynecologic cancers, lymphomas, and multiple myeloma, integrating molecular profiling and personalized therapies into care plans. Fluent in French, English, and Arabic, he is an active member of major international oncology societies and is widely recognized for his compassionate, evidence-based, and individualized approach to cancer treatment.
Dr. Miguel Ley Nacher
License: DHA
15 years of experience
Dr. Miguel Ley Nacher is a Consultant Neurologist and Epileptologist based at Al Zahra Hospital in Dubai, UAE.
Prior to relocating to the UAE, Dr. Ley served at Hospital del Mar, a Spanish national reference center for refractory epilepsy. He specializes in drug‑resistant epilepsy, with expertise in continuous video‑EEG monitoring, SEEG‑guided intracranial electrode implantation, and resective epilepsy surgery.
He is experienced in advanced neuroimaging, robotic‑assisted interventions, electrical source imaging, and laser interstitial thermal ablation, and manages status epilepticus in both ICU and emergency settings. Dr. Ley Nacher is recognized for his precision, innovation, and leadership in the management of complex epilepsy cases.
